↓ Skip to main content

Dove Medical Press

Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin

Overview of attention for article published in Drug Design, Development and Therapy, August 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
72 Mendeley
Title
Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
Published in
Drug Design, Development and Therapy, August 2020
DOI 10.2147/dddt.s251144
Pubmed ID
Authors

Yahdiana Harahap, Puspitasari Ardiningsih, Agatha Corintias Winarti, Denni Joko Purwanto

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 14%
Student > Master 6 8%
Student > Ph. D. Student 5 7%
Researcher 2 3%
Student > Postgraduate 2 3%
Other 6 8%
Unknown 41 57%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 14 19%
Medicine and Dentistry 5 7%
Chemistry 4 6%
Engineering 2 3%
Nursing and Health Professions 1 1%
Other 5 7%
Unknown 41 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2020.
All research outputs
#23,183,846
of 25,838,141 outputs
Outputs from Drug Design, Development and Therapy
#1,769
of 2,284 outputs
Outputs of similar age
#370,525
of 428,552 outputs
Outputs of similar age from Drug Design, Development and Therapy
#35
of 40 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 428,552 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.